The Resource for your Nonhuman Primate Research

We offer primate antibodies and recombinant proteins for pre-clinical NHP studies, NHP-specific reagents for in vitro assays, and have an industry wide antibody reactivity database for NHP species.

Recent Publications Using Our Reagents...


Have you tried measuring anti-drug antibodies using our reagents?

Check our Anti-rhesus IgG1/3 [1B3] clone (reacts with monkey but not human IgGs!)

2022 May 05

Single-Cell Profiling of Latently SIV-Infected CD4+ T Cells Directly Ex Vivo to Reveal Host Factors Supporting Reservoir Persistence.

Tokarev, Andrey Machmach, Kawthar Creegan, Matthew Kim, Dohoon Eller, Michael A Bolton, Diane L

Microbiol Spectr

Anti-CD38 [OKT10]-PE

2022 May 01

Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.

Zhu, Daniel Y Gorman, Matthew J Yuan, Dansu Yu, Jingyou Mercado, Noe B McMahan, Katherine Borducchi, Erica N Lifton, Michelle Liu, Jinyan Nampanya, Felix Patel, Shivani Peter, Lauren Tostanoski, Lisa H Pessaint, Laurent Van Ry, Alex Finneyfrock, Brad Velasco, Jason Teow, Elyse Brown, Renita Cook, Anthony Andersen, Hanne Lewis, Mark G Lauffenburger, Douglas A Barouch, Dan H Alter, Galit

PLoS Biol

Anti-rhesus IgG1/3 [1B3]-HRP

News & Updates:

2022 Jan 13

RhATG Discontinuation

We will discontinue the production of rhATG in 2022. Please find the reasons behind this decision on the attached letter (PDF).

2021 Apr 02

Stabilized Spike Glycoproteins for COVID Research

We have produced stabilized Spike proteins for NIAID, now offered through BEI. Please check the details on the constructs and order them directly from (cat. NR-52724, NR-53937)


2021 Sep 07

Anti-IFNAR therapeutic antibody now available

The rhesus recombinant anti-Interferon alpha receptor (IFNAR) 1 'Anti-IFNAR [Ani]' is now available for distribution. This antibody binds to the receptor blocking the activity of type I interferons.


2021 Feb 15

How to Cite Our Reagents Using RRIDs

We are now using Research Resource Identifiers (RRIDs) on our entire catalog to facilitate proper antibody identification. The idea behind the use of resource identifiers is simple: citation of our antibodies (using unique RRIDs) will automatically associate specific reagents with your publication.

Contribute to the Resource

Help Us By:

Sharing Your Data: Our community-based reactivity database is built by users like you. Share your results!

Requesting a Reagent: We develop NHP-specific antibodies based on investigator-initiated requests, including: recombinant proteins for cell depletion, receptor activation, cytokine neutralization, co-stimulatory blockade, immunosuppression.

Licensing Our Reagents: Interested in using our antibodies on your assays? Reach us!

Sharing Your Publication: If you’ve recently published a study using an NHPRR reagent, add it to the publication database.